Liberty Mutual Fire Insurance v. JM Smith Corporation

602 F. App'x 115
CourtCourt of Appeals for the Fourth Circuit
DecidedMarch 13, 2015
Docket13-2451
StatusUnpublished
Cited by3 cases

This text of 602 F. App'x 115 (Liberty Mutual Fire Insurance v. JM Smith Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Liberty Mutual Fire Insurance v. JM Smith Corporation, 602 F. App'x 115 (4th Cir. 2015).

Opinion

Affirmed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Liberty Mutual appeals a district court ruling that it had a duty to defend its insured, the J M Smith Corporation, in a lawsuit brought by the state of West Virginia. Because the claims alleged in the West Virginia complaint create a possibility of coverage under the commercial general liability insurance policy that Liberty Mutual issued to J M Smith, we hold that Liberty Mutual has a duty to defend in the West Virginia case. We therefore affirm the judgment of the district court.

*117 I.

J M Smith Corporation, along with its division Smith Drug Company, Inc. (collectively “J M Smith”), is a South Carolina wholesale pharmaceutical distributor. Since at least 2000, J M Smith has been insured by Liberty Mutual, a Wisconsin corporation, under annual commercial general liability (CGL) insurance policies. Among other things, these policies require Liberty Mutual to defend J M Smith against any suit seeking damages for bodily injury or property damage resulting from an “occurrence.” J.A. 117. Under the policy, an “occurrence” is defined as “an accident, including continuous or repeated exposure to substantially the same general harmful conditions.” J.A. 130. “Accident,” however, is left undefined.

On June 26, 2012, while J M Smith was insured by Liberty Mutual, the Attorney General of West Virginia sued J M Smith and twelve other wholesale drug distributors operating in the state. The complaint (“West Virginia Complaint”) alleged that the drug distributors were contributing to a well-publicized prescription drug abuse epidemic in West Virginia by failing to identify, block, and report excessive drug orders. It identified “pill mills” — physicians, pharmacists, and distributors of controlled substances who write and fill excessive prescriptions — as responsible for increased abuses. The complaint also charged the drug distributors with “substantially contributing to” the epidemic by failing to maintain sufficient controls that would flag suspicious orders as required by West Virginia law, all while the distributors were on notice that the epidemic was a current and growing problem. West Virginia requested damages and equitable relief for the harms caused to the state by the companies’ alleged contributions to the epidemic.

A.

Given that the duty to defend depends on the possibility of insurance coverage arising from the specific allegations in the West Virginia complaint, we touch briefly on the details of the often overlapping eight counts West Virginia alleged against the thirteen defendants.

West Virginia first requested injunctive relief to prevent the defendants from “willfully and repeatedly” violating the Uniform Controlled Substances Act by failing, among other things, “to provide effective controls and procedures to guard against diversion of controlled substances in contravention of West Virginia law.” J.A. 147 (W.Va.Complaint). West Virginia contended that failing to enjoin these violations would result in further losses “as the proximate result of the failure by the Defendants to monitor and to disclose suspicious orders of controlled substances.” J.A. 147 (W.Va.Complaint).

Second, West Virginia requested damages for “Negligence and Violations of the West Virginia Uniform Controlled Substances Act.” J.A. 148 (W.Va.Complaint). West Virginia alleged that the defendants were required to know their customer base and that, instead, they “willfully turned a blind eye towards the actual facts” of the drug abuse epidemic by “negligently act[ing] with others to violate West Virginia’s drug laws” and “creat[e] conditions which contribute^] to the violations of [these] laws.” J.A. 149 (W.Va.Complaint).

Third, the state alleged that the defendants had repeatedly and willfully violated regulations promulgated under the Uniform West Virginia Controlled Substances Act requiring companies to obtain a controlled substance permit, maintain “effective controls and procedures to guard against theft and diversion of controlled substances,” and “operate a system to dis *118 close [] suspicious orders of controlled substances” that deviate from normal patterns in size or frequency. J.A. 150-151 (W.Va.Complaint). West Virginia alleged that these violations constituted unfair or deceptive acts or practices in violation of the West Virginia Consumer Credit and. Protection Act. J.A. 150-151 (W.Va.Complaint).

Count IV alleged that the defendants had “negligently, recklessly, and/or intentionally” distributed controlled substances known to be abused, “in such quantities and with such frequency” that the defendants “knew or should have known” that the prescriptions were not for “legitimate medical purposes.” J.A. 152 (W.Va.Complaint). By doing so with a “blind indifference to the facts” of the prescription drug abuse epidemic, the state charged the defendants with creating a public nuisance.

The fifth count alleged that the defendants had been unjustly enriched by earning money distributing drugs that were not for legitimate medical purposes and by not having to pay the costs incurred by the state as a result of prescription drug abuses. J.A. 154 (W.Va.Complaint).

Count VI, entitled “Negligence,” alleged a breach of the “duty to exercise reasonable care in the marketing, promotion and distribution of controlled substances,” as well as negligence in “failing to guard against third-party misconduct” in the form of “pill mills.” J.A. 155 (W.Va.Complaint). The state claimed that the defendants breached their duty of “care, prudence, watchfulness, and vigilance commensurate to the dangers involved in the transaction of its business,” a business which posed “distinctive and significant dangers” that the defendants failed to acquire “special knowledge and special skills” to prevent or ameliorate. J.A. 156 (WVa.Complaint). The complaint incorporated earlier allegations to demonstrate conduct that breached proper care. J.A. 155 (W.Va.Complaint).

Count VII requested a fund for medical monitoring to treat patients who had become prescription drug abusers as a result of the defendant’s negligent and unlawful conduct. *

Finally, the eighth count alleged the defendants violated antitrust laws by conspiring with “pill mill” physicians and pharmacies to engage in “unfair and deceptive business practices to obtain [a] dominant market share” in West Virginia. J.A. 158159. It alleged that by prescribing, filling and distributing controlled substances for illegitimate, non-medical uses, the pill mills — including defendants— gained an unfair advantage over drug distributors that complied with regulations and established sufficient controls. J.A. 159 (W.Va.Complaint).

B.

On September 28, 2012, Liberty Mutual filed a complaint in South Carolina district court seeking a declaratory judgment that it had no duty to defend or indemnify J M Smith in the underlying West Virginia suit. Liberty Mutual moved for summary judg-mént on the ground that the West Virginia Complaint had not alleged an “occurrence” under the policy, and J M Smith likewise moved for summary judgment on .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Traveler's Prop. Cas. Co. of Am. v. Actavis, Inc.
225 Cal. Rptr. 3d 5 (California Court of Appeals, 5th District, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
602 F. App'x 115, Counsel Stack Legal Research, https://law.counselstack.com/opinion/liberty-mutual-fire-insurance-v-jm-smith-corporation-ca4-2015.